Understanding comorbidity between substance use, anxiety and affective disorders: Broadening the research base

Addictive Behaviors

Volumn 34, Issue 6-7, 2009, Pages 526-530

  Hall, Wayne ^a   Degenhardt, Louisa ^b   Teesson, Maree ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Affective disorders; Alcohol use disorder; Anxiety disorders; Comorbidity; Conduct disorder; Drug use disorder

Indexed keywords

ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BRAIN DEVELOPMENT; COMORBIDITY; CONDUCT DISORDER; DRUG ABUSE; DRUG USE; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; HEALTH PROGRAM; HEREDITY; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOOD DISORDER; NEUROIMAGING; PROPHYLAXIS; PROSPECTIVE STUDY; SECONDARY PREVENTION; SUBSTANCE ABUSE;

ADOLESCENT; ANXIETY DISORDERS; CHILD; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MOOD DISORDERS; RESEARCH DESIGN; SUBSTANCE-RELATED DISORDERS;

EID: 67349285363     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2009.03.010     Document Type: Article

References (67)

1. Andrews G., Hall W.D., and Henderson S. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. British Journal of Psychiatry 178 (2001) 145-153
2. Andrews G., Hall W.D., Teesson M., and Henderson S. The mental health of Australians (1999), Mental Health Branch, Commonwealth Department of Health and Aged Care, Canberra. http://www.health.gov.au/ http://www.health.gov.au/ (accessed 7 October 2008)
3. Baillie A., and Sannibale C. Anxiety and drug and alcohol problems. In: Baker A., and Velleman R. (Eds). Clinical handbook of co-existing mental health and drug and alcohol problems (2007), Routledge, London 197-217
4. Bartels S.J., Drake R.E., and McHugo G.J. Alcohol abuse, depression, and suicidal behavior in schizophrenia. American Journal of Psychiatry 149 (1992) 394-395
5. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin 2 (1946) 47-53
6. Bosworth K., Gustafson D., and Hawkins R. The BARN system: Use and impact of adolescent health and promotion via computer. Computers in Human Behavior 10 (1994) 467-482
7. Botvin G.B., and Griffin K.W. Drug abuse prevention curricula in schools. In: Sloboda Z., and Bukoski W.J. (Eds). Handbook of drug abuse prevention: Theory, science and practice (2003), Kluwer Academic / Plenum Publishers, New York 45-74
8. Burns L., and Teesson M. Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well-being. Drug and Alcohol Dependence 68 (2002) 299-307
9. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57 (2005) 1117-1127
10. Cerda M., Sagdeo A., and Galea S. Comorbid forms of psychopathology: Key patterns and future research directions. Epidemiologic Reviews 30 (2008) 155-177
11. Chan Y.F., Dennis M.L., and Funk R.R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment 34 (2008) 14-24
12. Christensen H. Web-based prevention of mental health problems. Auseinetter 13 2 (2001) 13-14. http://auseinet.com/resources/auseinet/netter13/netter13_1.pdf Available from: http://auseinet.com/resources/auseinet/netter13/netter13_1.pdf (accessed 8 October 2008)
13. Clarke G.M., Hawkins W., Murphy M., Sheeber L., Lewinsohn P.M., and Seeley J.R. Targeted prevention for unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of group cognitive intervention. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995) 312-321
14. Clarke G.M., Hornbrook M., Lynch F., Polen M., Gale J., Beardslee W., et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Archives of General Psychiatry 58 (2001) 1127-1134
15. Clarke G.M., Rohde P., Lewinsohn P.M., Hops H., and Seeley J.R. Cognitive-behavioural treatment of adolescent depression: Efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry 38 (1999) 272-279
16. Cleary M., Hunt G., Matheson S., Siegfried N., and Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 1 (2008) CD001088
17. Compton W.M., Thomas Y.F., Stinson F.S., and Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 64 (2007) 566-576
18. Davis L., Uezato A., Newell J.M., and Frazier E. Major depression and comorbid substance use disorders. Current Opinion in Psychiatry 21 (2008) 14-18
19. de Graaf R., Bijl R.V., Smit F., Vollebergh W.A., and Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. American Journal of Psychiatry 159 (2002) 620-629
20. Degenhardt L., Hall W.D., and Lynskey M.T. Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use, other drug use disorders, affective and anxiety disorders, and psychosis. Addiction 96 (2001) 1603-1614
21. Drake R.E., Mueser K.T., Clark R.E., and Wallach M.A. The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66 (1996) 42-51
22. Farrell M., Howes S., Bebbington P., Brugha T., Jenkins R., Lewis G., et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. British Journal of Psychiatry 179 (2001) 432-437
23. Fergusson D.M., and Horwood L.J. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 92 (1997) 279-296
24. Galbaud du Fort G., Newman S., and Bland R. Psychiatric comorbidity and treatment seeking: sources of selection bias in the study of clinical populations. Journal of Nervous and Mental Disease 181 (1993) 467-474
25. Glantz M.D., Anthony J.C., Berglund P.A., Degenhardt L., Dierker L., Kalaydjian A.K., et al. Mental disorders as risk factors for later substance dependence: Estimates of optimal prevention and treatment benefits. Psychological Medicine (2008, Dec 2) 10.1017/S0033291708004510 [Electronic publication ahead of print]
26. Grant B.F., Goldstein R.B., Chou S.P., Huang B., Stinson F.S., Dawson D.A., et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Molecular Psychiatry (2008, Apr 22) 10.1038/mp.2008.1041 [Electronic publication ahead of print]
27. Gratzer D., Levitan R.D., Sheldon T., Toneatto T., Rector N.A., and Goering P. Lifetime rates of alcoholism in adults with anxiety, depression, or comorbid depression/anxiety: A community survey of Ontario. Journal of Affective Disorders 79 (2004) 209-215
28. Hall W.D., and Farrell M. Comorbidity of mental disorders with substance misuse. British Journal of Psychiatry 171 (1997) 4-5
29. Hansen W.B. School-based substance abuse prevention: A review of the state of the art in curriculum, 1980-1990. Health Education Research 7 (1992) 403-430
30. Hasin D.S., Stinson F.S., Ogburn E., and Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 64 (2007) 830-842
31. Jane-Llopis E., and Matytsina I. Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review 25 (2006) 515-536
32. Jessor R., and Jessor S.L. Problem behavior and psychosocial development: A longitudinal study of youth (1977), Academic Press, New York
33. John U., Meyer C., Rumpf H.J., and Hapke U. Smoking, nicotine dependence and psychiatric comorbidity: A population-based study including smoking cessation after 3 years. Drug and Alcohol Dependence 76 (2004) 287-295
34. Jorm A.F. National surveys of mental disorders: are they researching scientific facts or constructing useful myths?. Australian and New Zealand Journal of Psychiatry 40 (2006) 830-834
35. Kavanagh D.J., Mueser K.T., and Baker A. Management of comorbidity. In: Teesson M., and Proudfoot H. (Eds). Cormorbid mental disorders and substance use disorders: epidemiology, prevention and treatment (2003), Commonwealth of Australia, Canberra 78-120
36. Kendler K.S., and Prescott C.A. Genes, environment, and psychopathology: understanding the causes of psychiatric and substance use disorders (2006), Guilford Press, New York
37. Kessler R.C. The epidemiology of psychiatric comorbidity. In: Tsuang M., Tohen M., and Zahner G. (Eds). Textbook of psychiatric epidemiology (1995), John Wiley and Sons, New York
38. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62 (2005) 617-627
39. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51 (1994) 8-19
40. Kessler R.C., and Wang P.S. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annual Review of Public Health 29 (2008) 115-129
41. Lenroot R.K., and Giedd J.N. Brain development in children and adolescents: Insights from anatomical magnetic resonance imaging. Neuroscience and Biobehavioral Reviews 30 (2006) 718-729
42. Li L., Ma N., Li Z., Tan L., Liu J., Gong G., et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: A diffusion tensor imaging study. Brain Research 1168 (2007) 124-128
43. Lubman D.I., Yucel M., and Hall W.D. Substance use and the adolescent brain: A toxic combination?. Journal of Psychopharmacology 21 (2007) 792-794
44. Lynskey M.T., Glowinski A.L., Todorov A.A., Bucholz K.K., Madden P.A., Nelson E.C., et al. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Archives of General Psychiatry 61 (2004) 1026-1032
45. Lynskey M.T., Heath A.C., Bucholz K.K., and Slutske W.S. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 289 (2003) 427-433
46. Merikangas K.R., and Kalaydjian A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Current Opinion in Psychiatry 20 (2007) 353-358
47. Nunes E.V., and Levin F.R. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA 291 (2004) 1887-1896
48. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., and Hall W.D. Cannabis use and mental health in young people: Cohort study. British Medical Journal 325 (2002) 1195-1198
49. Raimo E.B., and Schuckit M.A. Alcohol dependence and mood disorders. Addictive Behaviors 23 (1998) 933-946
50. Reinherz H.Z., Giaconia R.M., Carmola Hauf A.M., Wasserman M.S., and Paradis A.D. General and specific childhood risk factors for depression and drug disorders by early adulthood. Journal of the American Academy of Child and Adolescent Psychiatry 39 (2000) 223-231
51. Rickert V.I., Graham C.J., Fisher R., Gottlib A., Trosclair M., and Jay S. A comparison of methods for alcohol and marijuana anticipatory guidance with adolescents. Journal of Adolescent Health 14 (1993) 225-230
52. Roona M.R., Streke A.V., Ochshorn P., Marshall D.M., and Palmer A.P. Identifying effective school-based substance abuse prevention interventions: Background paper for Prevention 2000 Summit (2000), Social Capital Development Corporation, Albany, NY. http://www.silvergategroup.com/public/PREV2000/Roona.pdf http://www.silvergategroup.com/public/PREV2000/Roona.pdf (accessed 10 October 2008)
53. Schuckit M.A., Tipp J.E., Bergman M., Reich W., Hesselbrock V.M., and Smith T.L. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychiatry 154 (1997) 948-957
54. Schuckit M.A., Tipp J.E., Bucholz K.K., Nurnberger Jr. J.I., Hesselbrock V.M., Crowe R.R., et al. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 92 (1997) 1289-1304
55. Selmi P., Klein M., Greist J., Sorrell S., and Erdman H. Computer administered cognitive-behavioral therapy for depression. American Journal of Psychiatry 147 (1990) 51-56
56. Tapert S.F., Caldwell L., and Burke C. Alcohol and the adolescent brain. Human studies. Alcohol Research and Health 28 (2005) 205-212
57. Teesson M., and Burns L. National comorbidity project (2001), Dept. of Health and Aged Care, Canberra
58. Teesson M., Mills K., Ross J., Darke S., Williamson A., and Havard A. The impact of treatment on 3 years' outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 103 (2008) 80-88
59. Teesson M., and Proudfoot H. Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment (2003), Commonwealth Department of Health and Ageing, Canberra
60. Tobler N.S. Meta-analysis of 143 adolescent drug prevention programs: Quantitative outcome results of program participants compared to a control or comparison group. Journal of Drug Issues 16 (1986) 537-567
61. Tobler N.S., Lessard T., Marshall D.G., Ochshorn P., and Roona M.R. Effectiveness of school-based drug prevention programs for marijuana use. School Psychology International 20 (1999) 105-137
62. Tobler N.S., Roona M.R., Ochshorn P., Marshall D.G., Streke A.V., and Stackpole K.M. School-based adolescent drug prevention programs: 1998 meta-analysis. Journal of Primary Prevention 20 (2000) 275-336
63. Tobler N.S., and Stratton H.H. Effectiveness of school-based drug prevention programs: A meta-analysis of the research. The Journal of Primary Prevention 18 (1997) 71-128
64. Torrens M., Fonseca F., Mateu G., and Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug and Alcohol Dependence 78 (2005) 1-22
65. White D., and Pitts M. Health promotion with young people for the prevention of substance misuse (1997), Health Education Authority, London. http://www.york.ac.uk/inst/crd/projects/substance_misuse.htm http://www.york.ac.uk/inst/crd/projects/substance_misuse.htm (accessed 10 October 2008)
66. White D., and Pitts M. Educating young people about drugs: A systematic review. Addiction 93 (1998) 1475-1487
67. Wilson D.B., Gottfredson D.C., and Najaka S.S. School-based prevention of problem behaviors: A meta-analysis. Journal of Quantitative Criminology 17 (2001) 247-272